FYERS
Home
/
Stocks
/
Results
/
Suven Life Sciences Results

Suven Life Sciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-35%-12%-19%7%
----72%
7%30%67%52%
-51%-83%-73%-102%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
SUVEN
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
335.05₹9671 Cr—-4.83-12.25-₹276 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2008Mar 2007Mar 2006Mar 2005Mar 2004
—————————————————
₹26 Cr₹22 Cr₹22 Cr₹22 Cr₹15 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹12 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr
₹157 Cr₹1 Cr₹0₹0₹0₹37 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹408 Cr₹87 Cr₹248 Cr₹354 Cr₹82 Cr₹58 Cr₹131 Cr₹226 Cr₹755 Cr₹654 Cr₹583 Cr₹547 Cr₹95 Cr₹96 Cr₹85 Cr₹76 Cr₹77 Cr
₹408 Cr₹87 Cr₹248 Cr₹354 Cr₹82 Cr₹58 Cr₹131 Cr₹226 Cr₹755 Cr₹654 Cr₹583 Cr₹547 Cr₹95 Cr₹96 Cr₹85 Cr₹76 Cr₹77 Cr
₹591 Cr₹110 Cr₹270 Cr₹375 Cr₹96 Cr₹108 Cr₹143 Cr₹239 Cr₹767 Cr₹667 Cr₹595 Cr₹559 Cr₹106 Cr₹102 Cr₹90 Cr₹81 Cr₹82 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹25 L₹23 Cr₹38 Cr₹55 Cr₹55 Cr₹41 Cr₹24 Cr₹20 Cr₹21 Cr
₹0₹0₹0₹0₹0₹39 L₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹6 Cr₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹6 Cr₹20 Cr₹23 Cr-₹2 Cr-₹5 Cr₹23 Cr₹2 Cr₹5 Cr₹7 Cr₹13 Cr₹10 Cr
₹12 Cr₹0₹0₹58 L₹2 Cr₹2 Cr₹3 Cr₹76 L₹1 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0
₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0₹0
₹14 Cr₹2 Cr₹1 Cr₹2 Cr₹4 Cr₹5 Cr₹12 Cr₹25 Cr₹30 Cr₹28 Cr₹41 Cr₹86 Cr₹57 Cr₹47 Cr₹31 Cr₹33 Cr₹31 Cr
—————————————————
₹5 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹6 Cr₹7 Cr₹57 Cr₹38 Cr₹36 Cr₹44 Cr₹20 Cr₹12 Cr₹12 Cr₹12 Cr₹7 Cr
₹12 Cr₹17 Cr₹10 Cr₹8 Cr₹5 Cr₹12 Cr₹20 Cr₹32 Cr₹29 Cr₹46 Cr₹48 Cr₹42 Cr₹63 L₹1 Cr₹29 L₹27 L₹21 L
₹0₹0₹0₹0₹0₹0₹0₹0₹31 Cr₹30 Cr₹24 Cr₹28 Cr₹0₹0₹0₹0₹0
₹2 Cr₹2 Cr₹1 Cr₹95 Cr₹95 Cr₹95 Cr₹94 Cr₹118 Cr₹109 Cr₹93 Cr₹103 Cr₹13 Cr₹14 Cr₹12 Cr₹10 Cr₹9 Cr₹9 Cr
₹19 Cr₹23 Cr₹14 Cr₹105 Cr₹102 Cr₹110 Cr₹120 Cr₹157 Cr₹226 Cr₹208 Cr₹211 Cr₹127 Cr₹35 Cr₹25 Cr₹22 Cr₹22 Cr₹16 Cr
₹624 Cr₹135 Cr₹285 Cr₹483 Cr₹202 Cr₹222 Cr₹275 Cr₹421 Cr₹1023 Cr₹903 Cr₹846 Cr₹773 Cr₹199 Cr₹173 Cr₹143 Cr₹136 Cr₹129 Cr
₹6 Cr₹6 Cr₹4 Cr₹0₹0₹0₹0₹8 L₹10 Cr₹9 Cr₹7 Cr₹12 Cr₹7 Cr₹4 Cr₹3 Cr₹6 Cr₹3 Cr
₹0₹0₹0₹0₹48 L₹1 Cr₹2 Cr₹3 Cr₹34 Cr₹71 Cr₹83 Cr₹109 Cr₹55 Cr₹41 Cr₹24 Cr₹20 Cr₹21 Cr
—————————————————
₹130 Cr₹113 Cr₹78 Cr₹88 Cr₹83 Cr₹67 Cr₹77 Cr₹39 Cr₹376 Cr₹349 Cr₹325 Cr₹291 Cr₹141 Cr₹120 Cr₹102 Cr₹89 Cr₹78 Cr
₹57 Cr₹53 Cr₹50 Cr₹51 Cr₹46 Cr₹46 Cr₹52 Cr₹17 Cr₹68 Cr₹43 Cr₹20 Cr₹119 Cr₹31 Cr₹25 Cr₹19 Cr₹14 Cr₹10 Cr
₹73 Cr₹60 Cr₹28 Cr₹37 Cr₹38 Cr₹21 Cr₹25 Cr₹22 Cr₹308 Cr₹306 Cr₹305 Cr₹172 Cr₹110 Cr₹96 Cr₹83 Cr₹74 Cr₹67 Cr
₹4 Cr₹97,000₹0₹0₹4 Cr₹5 Cr₹0₹2 L₹25 Cr₹10 Cr₹7 Cr₹107 Cr₹4 Cr₹5 Cr₹3 Cr₹3 Cr₹1 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹7 L₹7 L₹7 L₹0₹2 Cr₹5 Cr₹4 Cr₹7 Cr₹15 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹7 L₹7 L₹7 L₹0₹2 Cr₹5 Cr₹4 Cr₹7 Cr₹15 Cr
₹91 L₹5 L₹2 L₹11 L₹33 L₹0₹91 Cr₹0₹17 Cr₹6 Cr₹6 Cr₹11 Cr₹0₹0₹0₹0₹0
₹0₹0₹0₹100 Cr₹0₹0₹0₹0₹20 L₹20 L₹0₹1 Cr₹0₹0₹0₹0₹0
₹78 Cr₹60 Cr₹28 Cr₹137 Cr₹41 Cr₹26 Cr₹116 Cr₹22 Cr₹350 Cr₹322 Cr₹319 Cr₹291 Cr₹116 Cr₹106 Cr₹90 Cr₹85 Cr₹84 Cr
—————————————————
₹181 Cr₹22 Cr₹76 Cr₹46 Cr₹45 Cr₹9 L₹5 L₹223 Cr₹279 Cr₹301 Cr₹5 L₹4 L₹0₹0₹0₹0₹0
₹10 L₹24 L₹71 L₹0₹2 L₹14 L₹0₹0₹139 Cr₹93 Cr₹83 Cr₹82 Cr₹24 Cr₹23 Cr₹23 Cr₹19 Cr₹12 Cr
₹2 Cr₹1 Cr₹1 Cr₹81 L₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹62 Cr₹46 Cr₹54 Cr₹40 Cr₹36 Cr₹16 Cr₹15 Cr₹19 Cr₹11 Cr
₹337 Cr₹38 Cr₹164 Cr₹184 Cr₹6 Cr₹47 Cr₹15 Cr₹69 L₹28 Cr₹9 Cr₹241 Cr₹280 Cr₹3 Cr₹10 Cr₹1 Cr₹3 Cr₹12 Cr
₹5 Cr₹1 Cr₹3 Cr₹5 Cr₹1 Cr₹3 Cr₹35 L₹20 L₹14 Cr₹8 Cr₹3 Cr₹41 Cr₹5 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr
₹22 Cr₹13 Cr₹12 Cr₹109 Cr₹107 Cr₹145 Cr₹142 Cr₹172 Cr₹151 Cr₹125 Cr₹146 Cr₹34 Cr₹15 Cr₹14 Cr₹10 Cr₹9 Cr₹8 Cr
₹547 Cr₹75 Cr₹257 Cr₹345 Cr₹160 Cr₹197 Cr₹160 Cr₹398 Cr₹674 Cr₹581 Cr₹528 Cr₹477 Cr₹83 Cr₹68 Cr₹53 Cr₹51 Cr₹45 Cr
₹528 Cr₹52 Cr₹243 Cr₹240 Cr₹58 Cr₹87 Cr₹39 Cr₹241 Cr₹448 Cr₹373 Cr₹317 Cr₹350 Cr₹48 Cr₹43 Cr₹31 Cr₹30 Cr₹29 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹5 Cr₹2 L₹4 L₹6 L₹9 L₹11 L
₹624 Cr₹135 Cr₹285 Cr₹483 Cr₹202 Cr₹222 Cr₹275 Cr₹421 Cr₹1023 Cr₹903 Cr₹846 Cr₹773 Cr₹199 Cr₹173 Cr₹143 Cr₹136 Cr₹129 Cr
₹16₹5₹12₹17₹7₹6₹11₹19₹60₹52₹47₹44₹9₹35₹36₹32₹33
₹16₹5₹12₹17₹6₹5₹10₹17₹56₹48₹43₹40₹8₹32₹9₹8₹8

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2008Mar 2007Mar 2006Mar 2005Mar 2004
-₹276 Cr-₹161 Cr-₹106 Cr-₹118 Cr-₹122 Cr-₹77 Cr-₹106 Cr₹16 L₹196 Cr₹123 Cr₹98 Cr₹152 Cr₹6 Cr₹11 Cr₹6 Cr₹6 Cr₹8 Cr
-₹6 Cr-₹4 Cr-₹22 Cr-₹8 Cr-₹1 Cr-₹3 Cr-₹8 Cr-₹5 Cr₹10 Cr₹13 Cr₹11 Cr₹21 Cr₹11 Cr₹7 Cr₹7 Cr₹4 Cr₹3 Cr
-₹18 Cr₹10 Cr₹7 Cr₹11 Cr-₹4 Cr-₹15 Cr-₹17 Cr-₹33 Cr-₹92 Cr₹8 Cr-₹14 Cr₹8 Cr-₹13 Cr₹46 L-₹7 Cr-₹7 Cr-₹6 Cr
-₹301 Cr-₹155 Cr-₹122 Cr-₹115 Cr-₹127 Cr-₹95 Cr-₹132 Cr-₹38 Cr₹113 Cr₹144 Cr₹94 Cr₹181 Cr₹5 Cr₹18 Cr₹7 Cr₹3 Cr₹5 Cr
-₹301 Cr-₹154 Cr-₹115 Cr-₹116 Cr-₹128 Cr-₹96 Cr-₹135 Cr-₹53 Cr₹70 Cr₹109 Cr₹67 Cr₹143 Cr₹4 Cr₹16 Cr₹6 Cr₹2 Cr₹4 Cr
-₹462 Cr₹155 Cr₹94 Cr-₹248 Cr-₹22 Cr₹56 Cr₹146 Cr₹37 Cr-₹61 L-₹311 Cr-₹39 Cr-₹110 Cr-₹16 Cr-₹20 Cr-₹9 Cr-₹4 Cr-₹31 Cr
₹757 Cr-₹76 L-₹1 Cr₹396 Cr₹146 Cr₹35 Cr₹3 Cr₹5 Cr-₹52 Cr-₹30 Cr-₹68 Cr₹179 Cr₹6 Cr₹13 Cr₹3 Cr-₹8 Cr₹38 Cr
-₹7 Cr₹9 L-₹22 Cr₹32 Cr-₹4 Cr-₹5 Cr₹14 Cr-₹11 Cr₹17 Cr-₹232 Cr-₹39 Cr₹212 Cr-₹7 Cr₹8 Cr-₹1 Cr-₹10 Cr₹11 Cr
₹15 Cr₹15 Cr₹37 Cr₹5 Cr₹9 Cr₹15 Cr₹23 L₹18 Cr₹9 Cr₹241 Cr₹280 Cr₹68 Cr₹10 Cr₹1 Cr₹3 Cr₹12 Cr₹71 L
₹0₹0₹0₹0₹0₹0₹0-₹7 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10 L
₹8 Cr₹15 Cr₹15 Cr₹37 Cr₹5 Cr₹9 Cr₹15 Cr₹23 L₹26 Cr₹9 Cr₹241 Cr₹279 Cr₹3 Cr₹10 Cr₹1 Cr₹3 Cr₹12 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)338.50
Volume (₹)2.11 L
High (₹)339.15
Upper Circuit410.20
Low (₹)333.00
Lower Circuit273.50
Prev Close341.85
52W High (₹)403.35
Price335.05
52W Low (₹)124.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)9670.71 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book8.07
Book Value16.46
EPS (TTM)-12.47
Face Value1.00
ROE (%)-101.81

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SUVENNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
335.05-6.5 (-1.90%)
331.75
345.20
9,671Cr

Suven Life Sciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹-₹124.98Cr; with other income of ₹7.52Cr, profit before interest and tax came to ₹-₹127.14Cr. Interest expense was ₹47.6Lakh; PBT before exceptional items stood at ₹-₹127.61Cr. Cost mix (full year): raw materials ₹0 cr; employee cost ₹24.15Cr; depreciation ₹2.15Cr; other expenses ₹136.07Cr. Basis: consolidated annual results.

Suven Life Sciences Ltd Quaterly Results Key Takeaways

Suven Life Sciences Ltd reported ₹3.57Cr total income from operations in Jun 2026, softer than ₹1.52Cr in Mar 2026 but higher than ₹1.87Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹-₹124.98Cr; with other income of ₹7.52Cr, profit before interest and tax came to ₹-₹127.14Cr. Interest expense was ₹47.6Lakh, taking profit before tax to ₹-₹127.61Cr. After tax of ₹0 cr, profit after tax stood at ₹-₹127.61Cr (vs ₹-₹45.59Cr in Mar 2026 and ₹-₹51.52Cr in Jun 2025).